Abstract
Five children under 10 years of age were operated on with a Björk-Shiley disc valve. The mitral valve was replaced in four patients and the tricuspid valve in one. No hospital death, late death or thromboembolic episode was observed during the 155 patient-months of the follow-up. Moreover, a marked reduction in cardiomegaly was demonstrated to parallel the clinical improvement and low risk seen in adults. We feel that our experience might justify a more aggressive approach in the management of valvular disease in children of the younger age group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
